TNF and rheumatoid arthritis: In the present study, we demonstrate that TNF-α-derived smDCs also have therapeutic potential in advanced CIA mice with arthritic scores of 2~3, and this therapeutic function was still effective when combined with MTX, a first-line agent for RA treatment.